Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26

BACKGROUND: Recurrence of colorectal cancer (CRC) may arise due to the persistence of drug-resistant and cancer-initiating cells that survive exposure to chemotherapy. Proteins responsible for this recurrence include the chemokine receptor CXCR4, which is known to enable CRC metastasis, as well as t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutler, Murray J., Lowthers, Erica L., Richard, Cynthia L., Hajducek, Dagmar M., Spagnuolo, Paul A., Blay, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640216/
https://www.ncbi.nlm.nih.gov/pubmed/26552750
http://dx.doi.org/10.1186/s12885-015-1702-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640216/
https://www.ncbi.nlm.nih.gov/pubmed/26552750
http://dx.doi.org/10.1186/s12885-015-1702-2

Ejemplares similares